Abstract:Long non-coding RNAs (lncRNAs) are involved in the pathology of various tumors, including colorectal cancer (CRC). The crosstalk between carcinoma- associated fibroblasts (CAFs) and cancer cells in the tumor microenvironment promotes tumor development and confers chemoresistance. In this study, we further investigated the underlying tumor-promoting roles of CAFs and the molecular mediators involved in these processes. Methods: The AOM/DSS-induced colitis-associated cancer (CAC) mouse model was established, and RNA sequencing was performed. Small interfering RNA (siRNA) sequences were used to knock down H19. Cell apoptosis was measured by flow cytometry. SW480 cells with H19 stably knocked down were used to establish a xenograft model. The indicated protein levels in xenograft tumor tissues were confirmed by immunohistochemistry assay, and cell apoptosis was analyzed by TUNEL apoptosis assay. RNA-FISH and immunofluorescence assays were performed to assess the expression of H19 in tumor stroma and cancer nests. The AldeRed ALDH detection assay was performed to detect intracellular aldehyde dehydrogenase (ALDH) enzyme activity. Isolated exosomes were identified by transmission electron microscopy, nanoparticle tracking and Western blotting. Results: H19 was highly expressed in the tumor tissues of CAC mice compared with the expression in normal colon tissues. The up-regulation of H19 was also confirmed in CRC patient samples at different tumor node metastasis (TNM) stages. Moreover, H19 was associated with the stemness of colorectal cancer stem cells (CSCs) in CRC specimens. H19 promoted the stemness of CSCs and increased the frequency of tumor-initiating cells. RNA-FISH showed higher expression of H19 in tumor stroma than in cancer nests. Of note, H19 was enriched in CAF-derived conditioned medium and exosomes, which in turn promoted the stemness of CSCs and the chemoresistance of CRC cells in vitro and in vivo. Furthermore, H19 activated the β-catenin pathway via acting as a competing endogenous RNA sponge for miR-141 in CRC, while miR-141 significantly inhibited the stemness of CRC cells. Conclusion: CAFs promote the stemness and chemoresistance of CRC by transferring exosomal H19. H19 activated the β-catenin pathway via acting as a competing endogenous RNA sponge for miR-141, while miR-141 inhibited the stemness of CRC cells. Our findings indicate that H19 expressed by CAFs of the colorectal tumor stroma contributes to tumor development and chemoresistance.

The role of H19 lncRNA in conferring chemoresistance in cancer cells

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer

Correlation of Long Non-Coding Rna H19 Expression with Cisplatin-Resistance and Clinical Outcome in Lung Adenocarcinoma

The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers

The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers

LncRNA H19 Confers Chemoresistance in ERα-positive Breast Cancer Through Epigenetic Silencing of the Pro-Apoptotic Gene BIK

Role of long non-coding RNA H19 in therapy resistance of digestive system cancers

H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis

Carcinoma-associated Fibroblasts Promote the Stemness and Chemoresistance of Colorectal Cancer by Transferring Exosomal Lncrna H19

Critical roles of long noncoding RNA H19 in cancer

Exosome‐mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer

Inhibition of LncRNAH19 Has the Effect of Anti‐tumour and Enhancing Sensitivity to Gefitinib and Chemotherapy in Non‐small‐cell Lung Cancer in Vivo

Tumor‑released Lncrna H19 Promotes Gefitinib Resistance Via Packaging into Exosomes in Non‑small Cell Lung Cancer

Role of LncRNA H19 in tumor progression and treatment

Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma

Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells

The double-edged sword of H19 lncRNA: Insights into cancer therapy

Decreased expression of H19/miR-675 ameliorates hypoxia-induced oxaliplatin resistance in colorectal cancer

Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors

Correlation Between Long Non-Coding RNAs (lncrnas) H19 Expression and Trastuzumab Resistance in Breast Cancer